A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab.
作者信息
Bernardini Nicoletta, Skroza Nevena, Marraffa Federica, Prevete Elisabeth, Mambrin Alessandra, Proietti Ilaria, Tolino Ersilia, Caviglia Martina, Di Guardo Antonio, Rossi Giovanni, Volpe Salvatore, Bersani Giuseppe, Potenza Concetta
机构信息
Dermatology Unit "D. Innocenzi", Polo Pontino, Sapienza University of Rome, Rome, Italy.
Department of Human Neuroscience, Sapienza University of Rome, Rome, Italy.
出版信息
Dermatol Ther. 2022 Jul;35(7):e15533. doi: 10.1111/dth.15533. Epub 2022 May 4.
Abstract
摘要
相似文献
1
A case of twins affected by psoriasis, psoriatic arthritis and autism: Five years of efficacious and safe treatment with Secukinumab.一例双胞胎患银屑病、银屑病关节炎和自闭症：司库奇尤单抗五年有效且安全的治疗
Dermatol Ther. 2022 Jul;35(7):e15533. doi: 10.1111/dth.15533. Epub 2022 May 4.
2
A review of secukinumab in psoriasis treatment.司库奇尤单抗治疗银屑病的研究进展。
Immunotherapy. 2021 Feb;13(3):201-216. doi: 10.2217/imt-2020-0195. Epub 2020 Nov 18.
3
Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis.司库奇尤单抗治疗银屑病、银屑病关节炎或强直性脊柱炎患者结核再激活的相关性。
JAMA Dermatol. 2021 Jan 1;157(1):43-51. doi: 10.1001/jamadermatol.2020.3257.
4
Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment.接受司库奇尤单抗治疗的银屑病关节炎患者出现矛盾性脓疱性银屑病。
J Clin Rheumatol. 2020 Sep;26(6):e208-e209. doi: 10.1097/RHU.0000000000001076.
5
Secukinumab in the Treatment of Psoriasis and Psoriatic Arthritis: A Review of the Literature.司库奇尤单抗治疗银屑病和银屑病关节炎：文献综述
Skin Therapy Lett. 2017 Jul;22(4):1-6.
6
Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎中生物制剂的注射部位反应
J Drugs Dermatol. 2017 Jul 1;16(7):695-698.
7
Secukinumab retreatment associated psoriasis flare with pustules.司库奇尤单抗（一种生物制剂）治疗后银屑病复发伴脓疱。
J Dermatolog Treat. 2022 Mar;33(2):1107-1110. doi: 10.1080/09546634.2020.1782816. Epub 2020 Jun 19.
8
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data.司库奇尤单抗治疗中重度斑块状银屑病、银屑病关节炎和强直性脊柱炎患者五年的长期安全性：汇总临床试验和上市后监测数据的更新。
Acta Derm Venereol. 2022 Apr 27;102:adv00698. doi: 10.2340/actadv.v102.563.
9
Successful secukinumab treatment of erythrodermic psoriasis and psoriatic arthritis concomitant with severe noninfectious uveitis: a case report.司库奇尤单抗成功治疗红皮病型银屑病和银屑病关节炎并伴有严重非感染性葡萄膜炎：一例报告
J Int Med Res. 2020 Nov;48(11):300060520969494. doi: 10.1177/0300060520969494.
10
Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review.抗白细胞介素-17 药物治疗斑块状银屑病和银屑病关节炎：全面综述。
Am J Clin Dermatol. 2016 Feb;17(1):33-47. doi: 10.1007/s40257-015-0162-4.
引用本文的文献
1
Skin Care Supports Overall Well-Being.皮肤护理有助于整体健康。
Clin Cosmet Investig Dermatol. 2025 Aug 27;18:2013-2023. doi: 10.2147/CCID.S539786. eCollection 2025.
2
Advancing Dermatologic Equity for Individuals With Autism Through Awareness and Structural Reform.通过提高认识和结构改革，促进自闭症患者的皮肤健康公平。
Cureus. 2025 May 10;17(5):e83829. doi: 10.7759/cureus.83829. eCollection 2025 May.
3
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study.斑块状银屑病患者从司库奇尤单抗转换为依奇珠单抗治疗的疗效与安全性：一项多中心回顾性研究
J Pers Med. 2024 Dec 22;14(12):1169. doi: 10.3390/jpm14121169.
4
Link between the skin and autism spectrum disorder.皮肤与自闭症谱系障碍之间的联系。
Front Psychiatry. 2023 Oct 18;14:1265472. doi: 10.3389/fpsyt.2023.1265472. eCollection 2023.
本文引用的文献
1
Psoriatic patients treated with secukinumab reach high levels of minimal disease activity: results from the SUPREME study.接受司库奇尤单抗治疗的银屑病患者达到了高度的疾病低活动度：来自 SUPREME 研究的结果。
Eur J Dermatol. 2021 Oct 1;31(5):630-637. doi: 10.1684/ejd.2021.4150.
2
Novel Therapeutic Approaches and Targets for Treatment of Psoriasis.银屑病治疗的新型治疗方法与靶点
Curr Pharm Biotechnol. 2021;22(1):7-31. doi: 10.2174/1389201021666200629150231.
3
Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.Nrf2 激活剂，萝卜硫素通过抑制外周和大脑中 Th17 相关信号转导和纠正氧化还原失衡改善 BTBR T+tf/J 小鼠的自闭症样症状。
Behav Brain Res. 2019 May 17;364:213-224. doi: 10.1016/j.bbr.2019.02.031. Epub 2019 Feb 19.
4
Autism spectrum disorder.自闭症谱系障碍。
Lancet. 2018 Aug 11;392(10146):508-520. doi: 10.1016/S0140-6736(18)31129-2. Epub 2018 Aug 2.
5
An Overview of Autism Spectrum Disorder, Heterogeneity and Treatment Options.自闭症谱系障碍、异质性及治疗选择概述
Neurosci Bull. 2017 Apr;33(2):183-193. doi: 10.1007/s12264-017-0100-y. Epub 2017 Feb 17.
6
The Changing Epidemiology of Autism Spectrum Disorders.自闭症谱系障碍不断变化的流行病学特征。
Annu Rev Public Health. 2017 Mar 20;38:81-102. doi: 10.1146/annurev-publhealth-031816-044318. Epub 2016 Dec 21.
7
Immunological and autoimmune considerations of Autism Spectrum Disorders.自闭症谱系障碍的免疫学和自身免疫考虑。
J Autoimmun. 2013 Aug;44:1-7. doi: 10.1016/j.jaut.2013.05.005. Epub 2013 Jul 15.
8
Heritability of psoriasis in a large twin sample.大型双胞胎样本中银屑病的遗传性。
Br J Dermatol. 2013 Aug;169(2):412-6. doi: 10.1111/bjd.12375.
9
Elevated serum levels of interleukin-17A in children with autism.自闭症儿童血清白介素-17A 水平升高。
J Neuroinflammation. 2012 Jul 2;9:158. doi: 10.1186/1742-2094-9-158.
Zotero 插件